Artículo

Carbonic anhydrase inhibitors reduce cardiac dysfunction after sustained coronary artery ligation in rats

Vargas, Lorena Alejandra Icon; Pinilla, Oscar Andres Icon; Diaz, Romina Gisel Icon; Sepúlveda, Diana Elizabeth Icon; Swenson, Erik R. ; Perez, Nestor Gustavo Icon; Alvarez, Bernardo Icon

Otros responsables

Fecha

11/2016

Editorial

Elsevier Science Inc

Revista

Cardiovascular Pathology

Título del libro

Nombre del evento

Fecha del evento

Institución organizadora

ISSN

1054-8807

eISSN

ISBN

Idioma

Inglés

Tipo del evento

Clasificación temática

Resumen

Background Two potent carbonic anhydrase (CA) inhibitors with widely differing membrane permeability, poorly diffusible benzolamide (BZ), and highly diffusible ethoxzolamide (ETZ) were assessed to determine whether they can reduce cardiac dysfunction in rats subjected to coronary artery ligation (CAL)-induced myocardial infarction. Methods and results Rats with evidence of heart failure (HF) at 32 weeks following a permanent left anterior coronary artery occlusion were treated with placebo, BZ, or ETZ (4 mg kg�day−1) for 4 weeks at which time left ventricular function and structure were evaluated. Lung weight/body weight (LW/BW) ratio increased in CAL rats by 17�1% vs. control, suggesting pulmonary edema. There was a trend for BZ and ETZ to ameliorate the increase in LW/BW by almost 50% (9�5% and 9�8%, respectively, versus CAL) (P=.16, NS). Echocardiographic assessment showed decreased left ventricular midwall shortening in HF rats, 21�1% vs. control 32�1%, which was improved by BZ to 29�1% and ETZ to 27�1%, and reduced endocardial shortening in HF rats 38�3% vs. control 62�1%, partially restored by BZ and ETZ to ~50%. Expression of the hypoxia-inducible membrane-associated CAIX isoform increased by ~60% in HF rat hearts, and this effect was blocked by ETZ. Conclusions We conclude that CAL-induced myocardial interstitial fibrosis and associated decline in left ventricular function were diminished with BZ or ETZ treatment. The reductions in cardiac remodeling in HF with both ETZ and BZ CA inhibitors suggest that inhibition of a membrane-bound CA appears to be the critical site for this protection.

Colecciones

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-nd